Related Experiment Videos
Diagnostic procedure in suspected Graves' disease
Bernard Goichot1, Laurence Leenhardt2, Catherine Massart3
1Service de médecine interne, endocrinologie et nutrition, hôpital de Hautepierre, hôpitaux universitaires de Strasbourg, avenue Molière, 67098 Strasbourg cedex, France.
Annales D'Endocrinologie
|September 18, 2018
Summary
Diagnosing Graves' disease involves initial thyroid-stimulating hormone (TSH) testing. Anti-TSH-receptor antibody screening is recommended for confirmed thyrotoxicosis unless clinical signs are definitive.
Area of Science:
- Endocrinology
- Internal Medicine
- Diagnostic Procedures
Background:
- Graves' disease diagnostic procedures lack scientific study and exhibit international practice variability.
- Existing recommendations are limited and based on expert opinion rather than robust evidence.
Purpose of the Study:
- To present expert consensus recommendations for diagnosing suspected Graves' disease.
- To standardize diagnostic approaches in endocrinology practice.
Main Methods:
- Expert consensus meeting organized by the French Society of Endocrinology in 2016.
- Review of diagnostic pathways for suspected thyrotoxicosis and Graves' disease.
Main Results:
- First-line assessment for suspected thyrotoxicosis includes thyroid-stimulating hormone (TSH), free T4, and free T3 assays.
- Anti-TSH-receptor antibody screening is recommended for confirmed thyrotoxicosis with ambiguous clinical presentation.
- Scintigraphy and thyroid ultrasound are reserved for specific, less common diagnostic scenarios.
Conclusions:
- Established guidelines for Graves' disease diagnosis are presented.
- A stepwise diagnostic approach prioritizing biological assessment and antibody screening is recommended.
- Complementary etiological examinations are selectively used based on clinical and biological findings.